• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Infertility Market Trends

    ID: MRFR/LS/4687-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Infertility Market Research Report By Treatment Type (Assisted Reproductive Technology, Hormone Therapy, Surgery, Fertility Preservation), By End User (Hospitals, Fertility Clinics, Home Care Settings), By Gender (Female, Male), By Cause of Infertility (Ovulatory Disorders, Uterine or Cervical Abnormalities, Tubal Factors, Male Factor Infertility) and By Regional (North America, Europe, South A...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Infertility Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Trends

    Key Emerging Trends in the Infertility Market

    There is a striking ascent in the reception of customized medication in fertility medicines. Custom fitted methodologies in light of individual patient qualities, including hereditary variables, hormonal profiles, and way of life contemplations, improve the accuracy and viability of medications. The market is seeing a developing interest for egg-freezing administrations. Social egg freezing, richness conservation for clinical reasons, and postponed family arranging add to the rising use of oocyte cryopreservation, giving ladies choices for protecting their ripeness. Propels in male barrenness medicines are forming market elements. Imaginative methodologies in sperm recovery, testicular sperm extraction (TESE), and male regenerative wellbeing mediations address male component barrenness, offering more thorough answers for couples looking for fertility help. The combination of Man-made consciousness (simulated intelligence) is impacting patterns in fertility care. Artificial intelligence applications in diagnostics, treatment arranging, and prescient examination add to upgraded direction, customized treatment proposals, and worked on persistent results. Procedures for intrauterine insemination are being progressed on the lookout. The viability of IUI is expanded by upgraded sperm readiness strategies, cycle following, and controlled ovarian feeling regimens; these techniques give a less nosy choice to couples looking for help. Barrenness the executives puts a lot of accentuation on dietary and way of life changes. Advancing regenerative wellbeing and accomplishing better fertility results can be accomplished through all encompassing methodologies that address nourishment, work out, stress the board, and ecological variables. Normal Cycle IVF is acquiring consideration in the fertility market. This approach includes negligible ovarian excitement, expecting to recover a normally chosen egg during the lady's regular monthly cycle, giving an option to conventional IVF for specific patient populaces. A developing accentuation on mindfulness and schooling drives are noticed universally. Public mindfulness crusades, fertility training projects, and promotion endeavors plan to lessen disgrace, bring issues to light about richness issues, and engage people and couples to settle on informed conclusions about their regenerative wellbeing. The globalization of fertility in the travel industry is apparent. Cross-line conceptive consideration, where people look for ripeness medicines in various nations, is impacted by elements like expense contemplations, legitimate guidelines, and admittance to explicit medicines, adding to the internationalization of richness administrations. Propels in bias hereditary testing are forming market patterns. Thorough hereditary evaluating for transporter status, chromosomal irregularities, and innate circumstances before origination recognizes likely hereditary dangers, taking into consideration informed family arranging choices and customized fertility care.

    Market Summary

    As per Market Research Future analysis, the Infertility Market was valued at 2.04 USD Billion in 2024 and is projected to grow to 7.67 USD Billion by 2035, with a CAGR of 12.82% from 2025 to 2035. The market is driven by increasing awareness of infertility treatments, technological advancements, and rising lifestyle-related disorders affecting fertility.

    Key Market Trends & Highlights

    The Global Infertility Market is influenced by several key trends.

    • Assisted Reproductive Technology is expected to reach 7.67 USD Billion by 2035. Hormone Therapy is projected to grow to 6.0 USD Billion by 2035. Fertility Clinics are becoming critical players in providing personalized services. Telemedicine is transforming patient access to fertility specialists.

    Market Size & Forecast

    2024 Market Size USD 2.04 Billion
    2035 Market Size USD 7.67 Billion
    CAGR (2025-2035) 12.82%
    Largest Regional Market Share in 2024 North America.

    Major Players

    <p>Key players include Ferring Pharmaceuticals, Boston IVF, OvaScience, Thermo Fisher Scientific, and Merck KGaA.</p>

    Market Trends

    The Global Infertility Market is currently being impacted by a number of significant market trends that are driven by the evolution of societal norms and the advancement of medical technology. As a result of the increasing prevalence of infertility and the growing awareness of reproductive health issues, a greater number of couples are increasingly seeking fertility treatments. 

    <p>The Global Infertility Market is experiencing a notable shift towards advanced reproductive technologies, driven by increasing awareness and acceptance of fertility treatments among diverse populations.</p>

    U.S. Department of Health and Human Services

    Infertility Market Market Drivers

    Market Growth Projections

    The Global Infertility Market Industry is projected to experience substantial growth in the coming years. By 2024, the market is anticipated to reach 19.7 USD Billion, with further expansion expected to 30.5 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate (CAGR) of 4.03 percent from 2025 to 2035. Such projections highlight the increasing demand for infertility treatments and services, driven by factors such as rising infertility rates, technological advancements, and greater awareness. As the market evolves, stakeholders are likely to explore new opportunities for innovation and investment, positioning themselves to meet the needs of a growing patient population.

    Rising Prevalence of Infertility

    The Global Infertility Market Industry is witnessing a notable increase in infertility rates, attributed to various factors such as delayed childbearing and lifestyle changes. According to recent data, approximately 15 percent of couples globally experience infertility issues. This rising prevalence is driving demand for fertility treatments and services, contributing to the market's projected growth. By 2024, the market is expected to reach 19.7 USD Billion, reflecting a growing awareness and acceptance of assisted reproductive technologies. As more individuals seek solutions for infertility, the industry is likely to expand, fostering innovation in treatment options and enhancing patient access.

    Government Initiatives and Support

    Government policies and initiatives play a crucial role in shaping the Global Infertility Market Industry. Many countries are implementing programs to support infertility treatments, including funding for research and subsidies for patients. For example, some nations offer financial assistance for IVF procedures, making them more accessible to a broader population. These initiatives not only alleviate the financial burden on couples but also encourage the development of advanced fertility clinics and services. As governments recognize the importance of addressing infertility, the market is likely to benefit from increased investment and support, further driving growth in the coming years.

    Demographic Shifts and Lifestyle Changes

    Demographic changes, including an aging population and evolving lifestyle choices, are significantly impacting the Global Infertility Market Industry. As individuals prioritize education and career advancement, many are delaying family planning, which can lead to increased infertility rates. Additionally, lifestyle factors such as obesity, smoking, and stress are contributing to fertility challenges. These shifts necessitate a greater demand for fertility solutions, as couples seek to overcome the biological limitations associated with age and lifestyle. The market's growth is expected to reflect these demographic trends, with a notable increase in service utilization as awareness of fertility issues rises.

    Technological Advancements in Fertility Treatments

    Innovations in reproductive technologies are significantly influencing the Global Infertility Market Industry. Techniques such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT) are becoming increasingly sophisticated. These advancements not only improve success rates but also enhance patient experiences. For instance, the introduction of artificial intelligence in embryo selection has shown promising results in optimizing outcomes. As these technologies evolve, they are expected to attract more patients, thereby propelling the market forward. The anticipated growth trajectory suggests that by 2035, the market could reach 30.5 USD Billion, underscoring the importance of continuous innovation.

    Increasing Awareness and Acceptance of Fertility Treatments

    The Global Infertility Market Industry is experiencing a shift in societal attitudes towards fertility treatments. Increased awareness campaigns and educational initiatives are helping to destigmatize infertility and promote available treatment options. As a result, more individuals and couples are seeking assistance, leading to a rise in demand for fertility services. This trend is particularly evident in urban areas where access to information is more prevalent. The growing acceptance of assisted reproductive technologies is expected to contribute to a compound annual growth rate (CAGR) of 4.03 percent from 2025 to 2035, indicating a robust market expansion driven by informed consumer choices.

    Market Segment Insights

    Infertility Market Treatment Type Insights

    <p>The Global Infertility Market, particularly in the Treatment Type segment, showcases a diverse range of avenues catering to individuals facing fertility challenges. By 2024, the market is expected to see significant valuation, driven by escalating demand for innovative and effective treatments. One crucial area, Assisted Reproductive Technology, holds a dominant position, anticipated to reach a valuation of 8.5 USD Billion in 2024 and projected to grow to 12.8 USD Billion by 2035.&nbsp;</p>

    <p>This segment reflects its importance as a primary method for couples struggling with infertility, providing options like in vitro fertilization (IVF) that have a marked success rate. Hormone Therapy, another vital category within this market, is valued at approximately 4.0 USD Billion in 2024, with expectations of reaching 6.0 USD Billion in 2035. This treatment remains significant due to its role in regulating hormonal levels, thereby enhancing fertility potential.&nbsp;</p>

    <p>Surgery, capturing a valuation of 3.5 USD Billion in 2024 and expected to grow to 5.3 USD Billion by 2035, also plays a critical role, particularly in addressing physical obstructions or abnormalities that affect fertility. Furthermore, Fertility Preservation, valued at 3.74 USD Billion in 2024 and projected to reach 6.4 USD Billion in 2035, caters to individuals looking to safeguard their fertility for the future, often crucial for those considering delayed parenthood.Such growth trends in these treatment types underline the rising recognition of infertility as a serious health concern, driving both demand and innovation.&nbsp;</p>

    Infertility Market End User Insights

    <p>The Global Infertility Market revenue is significantly influenced by the End User segment, encompassing various healthcare settings that provide infertility treatments and related services. By 2024, the market is expected to be valued at 19.74 billion USD, reflecting a growing emphasis on the need for effective reproductive health solutions globally.&nbsp;</p>

    <p>Hospitals typically represent a considerable part of the Global Infertility Market segmentation, offering comprehensive care, advanced technology, and accessibility to specialists, which is vital for complex infertility cases.Fertility Clinics play an essential role in providing personalized services and innovative treatments tailored for couples facing fertility challenges, making them a critical player in the overall market dynamics. Home Care Settings are increasingly important as they offer convenience and a more comfortable environment for patients undergoing treatments, reflecting a trend toward more patient-centric care options.&nbsp;</p>

    <p>Overall, the market growth opportunities within these environments are supported by rising infertility awareness and increasing acceptance of assisted reproductive technologies worldwide, bolstering the Global Infertility Market industry and driving improvements in reproductive health outcomes.The evolving landscape highlights the importance of tailored care, underscoring the diverse needs within the Global Infertility Market data and enhancing patient experience.</p>

    Infertility Market Gender Insights

    <p>The Global Infertility Market is poised for significant growth, with a projected value of 19.74 billion USD in 2024 and reaching 30.5 billion USD by 2035. This market segmentation by Gender plays a crucial role in understanding the dynamics of infertility treatment across different demographics. The Female segment remains an essential focus due to various factors such as age-related fertility decline and increasing demand for assisted reproductive technologies.&nbsp;</p>

    <p>Meanwhile, the Male segment has also gained attention as male infertility contributes substantially to overall fertility challenges.In recent years, there has been growing awareness of male reproductive health issues, which is driving the need for innovative solutions. Additionally, the increased prevalence of lifestyle-related health issues, such as obesity and stress, impacts both genders and contributes to the demand for infertility treatments.&nbsp;</p>

    <p>The continuous advancements in Research and Development and the rise in support networks for couples facing infertility are further propelling the Global Infertility Market growth. Understanding this segmentation is vital, as both Female and Male segments are significant for shaping treatment strategies and addressing the personal and emotional aspects of infertility globally.</p>

    Infertility Market Cause of Infertility Insights

    <p>The Global Infertility Market revenue is significantly driven by the various causes of infertility, encompassing key areas such as Ovulatory Disorders, Uterine or Cervical Abnormalities, Tubal Factors, and Male Factor Infertility. As of 2024, the overall market is projected to reach a valuation of 19.74 billion USD, with an expected consistent growth trajectory towards 2035. Ovulatory Disorders frequently represent a substantial contributor to infertility, emphasizing the importance of effective diagnosis and treatment options.</p>

    <p>Meanwhile, Uterine or Cervical Abnormalities play a critical role in hindering conception, thereby further complicating fertility issues.Tubal Factors also significantly impact fertility rates, with blockages and damage to the fallopian tubes often necessitating advanced medical interventions. Male Factor Infertility is increasingly recognized as a dominant issue affecting couples; research indicates that this factor is essential for overall fertility assessments and treatments.&nbsp;</p>

    <p>The challenges in addressing these various infertility causes are met with evolving opportunities in the Global Infertility Market industry, driven by research and development efforts targeting more effective therapies and patient management strategies.</p>

    Get more detailed insights about Infertility Market Research Report – Forecast to 2035

    Regional Insights

    The Global Infertility Market demonstrates significant growth, with a comprehensive valuation reaching 19.74 USD Billion in 2024. Regionally, North America holds a majority share, valued at 7.52 USD Billion in 2024 and poised to grow to 11.2 USD Billion by 2035, reflecting substantial investment in reproductive health technologies and increasing awareness of infertility treatments. 

    Europe follows, with a valuation of 5.3 USD Billion in 2024, showcasing a well-established health infrastructure and favorable policies supporting infertility treatments, expected to reach 8.0 USD Billion by 2035.The Asia-Pacific (APAC) region, with a valuation of 4.3 USD Billion in 2024, is witnessing rapid urbanization and a rise in disposable income, which are driving factors for market growth, projected to increase to 6.7 USD Billion by 2035. 

    South America, though smaller, still contributes with a valuation of 1.4 USD Billion in 2024, as cultural shifts are beginning to increase the demand for infertility solutions, projected to reach 2.2 USD Billion by 2035. The Middle East and Africa (MEA) is also on the rise, valued at 1.22 USD Billion in 2024, reflecting potential due to improving healthcare access, expected to grow to 2.4 USD Billion by 2035.These regional dynamics underline the diverse landscape of the Global Infertility Market, driven by unique cultural, economic, and healthcare factors.

    Infertility Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Global Infertility Market has become a dynamic sector, driven by the increasing prevalence of infertility and the rising awareness of assisted reproductive technologies. Various factors, such as delayed marriages, lifestyle changes, and environmental influences, have contributed to the growing demand for infertility treatments across the globe. 

    As a result, numerous companies are vying for market share, offering a range of services from IVF procedures to hormone drugs and reproductive health services. Key players in the market are continually innovating and expanding their product offerings to meet the diverse needs of patients, making it increasingly competitive. 

    The market landscape is characterized by strategic partnerships, mergers, and acquisitions as companies seek to consolidate their positions and leverage complementary strengths in their pursuit of advancements in reproductive health.Ferring Pharmaceuticals has established a significant presence in the Global Infertility Market, recognized for its focus on reproductive medicine and women's health.

    The company is well-known for its dedication to innovation and research, continually investing in the development of cutting-edge fertility treatments designed to improve success rates for couples facing infertility challenges. Ferring Pharmaceuticals excels in delivering high-quality products and personalized services that cater to the varying needs of patients, further strengthening its market position. Their robust portfolio includes a range of hormone treatments that are pivotal in fertility protocols. 

    By maintaining an emphasis on scientific excellence and patient-centered approaches, Ferring Pharmaceuticals has managed to carve out a strong foothold in this competitive arena, fostering relationships with healthcare providers to support patient journeys through infertility treatment.Boston IVF has positioned itself firmly within the Global Infertility Market, known for its comprehensive services that encompass all facets of reproductive health. 

    The company offers a wide array of treatments, including IVF, egg freezing, and fertility preservation, supported by a commitment to utilizing advanced technologies and innovative techniques. Boston IVF focuses on personalized patient care, enhancing the overall experience for individuals seeking fertility solutions. The company’s strategic growth includes partnerships with various healthcare entities and participation in clinical trials to advance reproductive health knowledge and technology. 

    Furthermore, Boston IVF continues to expand its geographical footprint through strategic mergers and acquisitions aimed at enhancing accessibility to its wide range of services. The dedication of Boston IVF to delivering quality and excellence in patient outcomes underlines its strengths within the competitive landscape of the Global Infertility Market, showcasing its leadership and commitment to excellence in reproductive healthcare.

    Key Companies in the Infertility Market market include

    Industry Developments

    The Global Infertility Market has seen notable developments recently, driven by advancements in reproductive technologies and increased awareness surrounding infertility issues. Companies such as Ferring Pharmaceuticals, Boston IVF, and Merck KGaA have been actively involved in launching innovative fertility treatments. 

    For instance, in July 2023, Ferring Pharmaceuticals introduced a new product aimed at enhancing fertility efficiency, which is anticipated to improve patient outcomes. Significant mergers and acquisitions also characterize the market; Cook Medical acquired MediCorp in August 2023, aiming to expand its portfolio in reproductive health technologies, with major implications for collaboration and innovation in the sector. Furthermore, the valuation of companies like IVF Technologies and Vitrolife has surged due to rising demand for assisted reproductive technologies, reflecting a broader trend of increasing allocations towards Research and Development in this area. 

    Over the last couple of years, a substantial shift towards telemedicine in fertility consultations has transformed patient access and care, indicating evolving consumer preferences in the Global Infertility Market landscape. As awareness grows and technology advances, the market is poised for sustained growth in the upcoming years.

    Future Outlook

    Infertility Market Future Outlook

    <p>The Global Infertility Market is projected to grow at a 12.82% CAGR from 2025 to 2035, driven by advancements in reproductive technologies, increasing awareness, and rising infertility rates.</p>

    New opportunities lie in:

    • <p>Develop innovative fertility preservation solutions targeting younger demographics. Expand telehealth services for remote fertility consultations and treatments. Invest in AI-driven diagnostics to enhance personalized treatment plans.</p>

    <p>By 2035, the Global Infertility Market is expected to exhibit robust growth, reflecting evolving consumer needs and technological advancements.</p>

    Market Segmentation

    Infertility Market Gender Outlook

    • Female
    • Male

    Infertility Market End User Outlook

    • Hospitals
    • Fertility Clinics
    • Home Care Settings

    Infertility Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Infertility Market Treatment Type Outlook

    • Assisted Reproductive Technology
    • Hormone Therapy
    • Surgery
    • Fertility Preservation

    Infertility Market Cause of Infertility Outlook

    • Ovulatory Disorders
    • Uterine or Cervical Abnormalities
    • Tubal Factors
    • Male Factor Infertility

    Report Scope

    Report Attribute/Metric Source:Details
    MARKET SIZE 202318.97(USD Billion)
    MARKET SIZE 202419.74(USD Billion)
    MARKET SIZE 20357.67 (USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)12.82% (2025 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    MARKET FORECAST PERIOD2025 - 2035
    HISTORICAL DATA2019 - 2024
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDFerring Pharmaceuticals, Boston IVF, OvaScience, Thermo Fisher Scientific, Cook Medical, IVF Technologies, CryoBank, Merck KGaA, MediCorp, Vitrolife, Genea Limited, CooperSurgical, ReproTech, Irvine Scientific, Eugin Group
    SEGMENTS COVEREDTreatment Type, End User, Gender, Cause of Infertility, Regional
    KEY MARKET OPPORTUNITIESIncreased awareness and education, Advancements in reproductive technologies, Rising demand for IVF services, Growing investment in fertility clinics, Expansion of fertility preservation services
    KEY MARKET DYNAMICSRising infertility rates, Advancements in reproductive technology, Increasing public awareness, Government funding and support, Growing trend of delayed parenthood
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    Market Size 20242.04
    Market Size 20252.30
    Market Size 20357.67
    Base Year2024
    Market Forecast Period2025 - 2035

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected growth of the Infertility market?

    The Infertility market is the expected increase in total market value of 7.67 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Infertility market?

    Infertility market size was valued at approximately 2.04 billion USD in 2024. This figure will reach 7.67 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Infertility market?

    Infertility market is expected to grow at a CAGR of 12.82% between 2025 and 2035.

    How much will the Infertility market be worth by 2035?

    Infertility market is expected to be worth of 7.67 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Infertility market perform over the next 10 years?

    Over the next 10 years the Infertility market is expected to shift from usd billion 2.04 to 7.67 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    What is the expected market valuation for the Global Infertility Market by 2035?

    By 2035, the Global Infertility Market is anticipated to reach a valuation of 30.5 USD Billion.

    Which region is expected to have the largest market share in the Global Infertility Market in 2024?

    North America is anticipated to hold the largest market share, valued at 7.52 USD Billion in 2024.

    What will be the market size for Assisted Reproductive Technology by 2035?

    The market size for Assisted Reproductive Technology is expected to reach 12.8 USD Billion by 2035.

    Which key players are involved in the Global Infertility Market?

    Major players include Ferring Pharmaceuticals, Boston IVF, OvaScience, and Thermo Fisher Scientific.

    How is the European market for infertility expected to evolve by 2035?

    The European market for infertility is projected to grow to 8.0 USD Billion by 2035.

    No Data Available

    Infertility Market Segmentation

    Infertility Market By Treatment Type (USD Billion, 2019-2035)

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    Infertility Market By End User (USD Billion, 2019-2035)

    Hospitals

    Fertility Clinics

    Home Care Settings

    Infertility Market By Gender (USD Billion, 2019-2035)

    Female

    Male

    Infertility Market By Cause of Infertility (USD Billion, 2019-2035)

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    Infertility Market By Regional (USD Billion, 2019-2035)

    North America

    Europe

    South America

    Asia Pacific

    Middle East and Africa

    Infertility Market Regional Outlook (USD Billion, 2019-2035)

    North America Outlook (USD Billion, 2019-2035)

    North America Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    North America Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    North America Infertility Market by Gender Type

    Female

    Male

    North America Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    North America Infertility Market by Regional Type

    US

    Canada

    US Outlook (USD Billion, 2019-2035)

    US Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    US Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    US Infertility Market by Gender Type

    Female

    Male

    US Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    CANADA Outlook (USD Billion, 2019-2035)

    CANADA Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    CANADA Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    CANADA Infertility Market by Gender Type

    Female

    Male

    CANADA Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    Europe Outlook (USD Billion, 2019-2035)

    Europe Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    Europe Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    Europe Infertility Market by Gender Type

    Female

    Male

    Europe Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    Europe Infertility Market by Regional Type

    Germany

    UK

    France

    Russia

    Italy

    Spain

    Rest of Europe

    GERMANY Outlook (USD Billion, 2019-2035)

    GERMANY Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    GERMANY Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    GERMANY Infertility Market by Gender Type

    Female

    Male

    GERMANY Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    UK Outlook (USD Billion, 2019-2035)

    UK Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    UK Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    UK Infertility Market by Gender Type

    Female

    Male

    UK Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    FRANCE Outlook (USD Billion, 2019-2035)

    FRANCE Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    FRANCE Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    FRANCE Infertility Market by Gender Type

    Female

    Male

    FRANCE Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    RUSSIA Outlook (USD Billion, 2019-2035)

    RUSSIA Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    RUSSIA Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    RUSSIA Infertility Market by Gender Type

    Female

    Male

    RUSSIA Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    ITALY Outlook (USD Billion, 2019-2035)

    ITALY Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    ITALY Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    ITALY Infertility Market by Gender Type

    Female

    Male

    ITALY Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    SPAIN Outlook (USD Billion, 2019-2035)

    SPAIN Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    SPAIN Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    SPAIN Infertility Market by Gender Type

    Female

    Male

    SPAIN Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    REST OF EUROPE Outlook (USD Billion, 2019-2035)

    REST OF EUROPE Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    REST OF EUROPE Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    REST OF EUROPE Infertility Market by Gender Type

    Female

    Male

    REST OF EUROPE Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    APAC Outlook (USD Billion, 2019-2035)

    APAC Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    APAC Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    APAC Infertility Market by Gender Type

    Female

    Male

    APAC Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    APAC Infertility Market by Regional Type

    China

    India

    Japan

    South Korea

    Malaysia

    Thailand

    Indonesia

    Rest of APAC

    CHINA Outlook (USD Billion, 2019-2035)

    CHINA Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    CHINA Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    CHINA Infertility Market by Gender Type

    Female

    Male

    CHINA Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    INDIA Outlook (USD Billion, 2019-2035)

    INDIA Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    INDIA Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    INDIA Infertility Market by Gender Type

    Female

    Male

    INDIA Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    JAPAN Outlook (USD Billion, 2019-2035)

    JAPAN Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    JAPAN Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    JAPAN Infertility Market by Gender Type

    Female

    Male

    JAPAN Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    SOUTH KOREA Outlook (USD Billion, 2019-2035)

    SOUTH KOREA Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    SOUTH KOREA Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    SOUTH KOREA Infertility Market by Gender Type

    Female

    Male

    SOUTH KOREA Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    MALAYSIA Outlook (USD Billion, 2019-2035)

    MALAYSIA Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    MALAYSIA Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    MALAYSIA Infertility Market by Gender Type

    Female

    Male

    MALAYSIA Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    THAILAND Outlook (USD Billion, 2019-2035)

    THAILAND Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    THAILAND Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    THAILAND Infertility Market by Gender Type

    Female

    Male

    THAILAND Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    INDONESIA Outlook (USD Billion, 2019-2035)

    INDONESIA Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    INDONESIA Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    INDONESIA Infertility Market by Gender Type

    Female

    Male

    INDONESIA Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    REST OF APAC Outlook (USD Billion, 2019-2035)

    REST OF APAC Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    REST OF APAC Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    REST OF APAC Infertility Market by Gender Type

    Female

    Male

    REST OF APAC Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    South America Outlook (USD Billion, 2019-2035)

    South America Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    South America Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    South America Infertility Market by Gender Type

    Female

    Male

    South America Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    South America Infertility Market by Regional Type

    Brazil

    Mexico

    Argentina

    Rest of South America

    BRAZIL Outlook (USD Billion, 2019-2035)

    BRAZIL Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    BRAZIL Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    BRAZIL Infertility Market by Gender Type

    Female

    Male

    BRAZIL Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    MEXICO Outlook (USD Billion, 2019-2035)

    MEXICO Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    MEXICO Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    MEXICO Infertility Market by Gender Type

    Female

    Male

    MEXICO Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    ARGENTINA Outlook (USD Billion, 2019-2035)

    ARGENTINA Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    ARGENTINA Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    ARGENTINA Infertility Market by Gender Type

    Female

    Male

    ARGENTINA Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

    REST OF SOUTH AMERICA Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    REST OF SOUTH AMERICA Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    REST OF SOUTH AMERICA Infertility Market by Gender Type

    Female

    Male

    REST OF SOUTH AMERICA Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    MEA Outlook (USD Billion, 2019-2035)

    MEA Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    MEA Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    MEA Infertility Market by Gender Type

    Female

    Male

    MEA Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    MEA Infertility Market by Regional Type

    GCC Countries

    South Africa

    Rest of MEA

    GCC COUNTRIES Outlook (USD Billion, 2019-2035)

    GCC COUNTRIES Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    GCC COUNTRIES Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    GCC COUNTRIES Infertility Market by Gender Type

    Female

    Male

    GCC COUNTRIES Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    SOUTH AFRICA Outlook (USD Billion, 2019-2035)

    SOUTH AFRICA Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    SOUTH AFRICA Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    SOUTH AFRICA Infertility Market by Gender Type

    Female

    Male

    SOUTH AFRICA Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

    REST OF MEA Outlook (USD Billion, 2019-2035)

    REST OF MEA Infertility Market by Treatment Type

    Assisted Reproductive Technology

    Hormone Therapy

    Surgery

    Fertility Preservation

    REST OF MEA Infertility Market by End User Type

    Hospitals

    Fertility Clinics

    Home Care Settings

    REST OF MEA Infertility Market by Gender Type

    Female

    Male

    REST OF MEA Infertility Market by Cause of Infertility Type

    Ovulatory Disorders

    Uterine or Cervical Abnormalities

    Tubal Factors

    Male Factor Infertility

     

     

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027